Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015, Article ID 968567, 4 pages
http://dx.doi.org/10.1155/2015/968567
Case Report

Simultaneous Low- and High-Grade Primary Leiomyosarcomas in Two Separate Organs in a Thirty-Year Survivor of Hereditary Retinoblastoma

1Department of Internal Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA
2Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA
3Department of Hematology/Oncology, Children’s Mercy Hospital, Kansas City, MO 64108, USA
4School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA

Received 9 November 2015; Accepted 13 December 2015

Academic Editor: Nurdan Tacyildiz

Copyright © 2015 Katherine Moore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Venkatraman, J. R. Goepel, K. Steele, S. P. Dobbs, R. W. Lyness, and W. G. McCluggage, “Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma,” Journal of Clinical Pathology, vol. 56, no. 3, pp. 233–236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. T. R. Guse and L. D. Weis, “Leiomyosarcoma of the femur in a patient with a history of retinoblastoma. A case report,” The Journal of Bone & Joint Surgery—American Volume, vol. 76, no. 6, pp. 904–906, 1994. View at Google Scholar · View at Scopus
  3. N. Abdelli, G. Thiefin, M.-D. Diebold, O. Bouche, J.-P. Aucouturier, and P. Zeitoun, “Primary leiomyosarcoma of the liver 37 years after successful treatment of hereditary retinoblastoma,” Gastroenterologie Clinique et Biologique, vol. 20, no. 5, pp. 502–505, 1996. View at Google Scholar · View at Scopus
  4. R. A. Kleinerman, M. A. Tucker, R. E. Tarone et al., “Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up,” Journal of Clinical Oncology, vol. 23, no. 10, pp. 2272–2279, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Tucker, G. J. D'Angio, J. D. Boice Jr. et al., “Bone sarcomas linked to radiotherapy and chemotherapy in children,” The New England Journal of Medicine, vol. 317, no. 10, pp. 588–593, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Kleinerman, M. A. Tucker, D. H. Abramson, J. M. Seddon, R. E. Tarone, and J. F. Fraumeni, “Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma,” Journal of the National Cancer Institute, vol. 99, no. 1, pp. 24–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. D. H. Abramson, M. R. Melson, I. J. Dunkel, and C. M. Frank, “Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma,” Ophthalmology, vol. 108, no. 10, pp. 1868–1876, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. X. Liang, Y. Lakshmanan, B. A. Woda, and Z. Jiang, “A high-grade primary leiomyosarcoma of the bladder in a survivor of retinoblastoma,” Archives of Pathology & Laboratory Medicine, vol. 125, no. 9, pp. 1231–1234, 2001. View at Google Scholar · View at Scopus
  9. F. L. Wong, J. D. Boice Jr., D. H. Abramson et al., “Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk,” The Journal of the American Medical Association, vol. 278, no. 15, pp. 1262–1267, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Motta, A. B. Porcaro, V. Ficarra, A. D'Amico, Q. Piubello, and L. Comunale, “Leiomyosarcoma of the bladder fourteen years after cyclophosphamide therapy for retinoblastoma,” Scandinavian Journal of Urology and Nephrology, vol. 35, no. 3, pp. 248–249, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Kawamura, M. Sakurai, K. Tsukamoto, and H. Tochigi, “Leiomyosarcoma of the bladder eighteen years after cyclophosphamide therapy for retinoblastoma,” Urologia Internationalis, vol. 51, no. 1, pp. 49–53, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. Al-Zahrani, B. A. Kamal, H. M. Eldarawani, and T. M. Hashim, “Leiomyosarcoma of the bladder in a 16-year-old girl with a history of cyclophosphamide therapy for bilateral retinoblastoma during infancy,” Saudi Medical Journal, vol. 27, no. 4, pp. 531–533, 2006. View at Google Scholar · View at Scopus
  13. S. L. Bléoo, R. Godbout, D. Rayner, Y. Tamimi, and R. B. Moore, “Leiomyosarcoma of the bladder in a retinoblastoma patient,” Urologia Internationalis, vol. 71, no. 1, pp. 118–121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. B. Thrasher, G. J. Miller, and J. N. Wettlaufer, “Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis,” The Journal of Urology, vol. 143, no. 1, pp. 119–121, 1990. View at Google Scholar · View at Scopus
  15. Y.-L. Zhai, T. Nikaido, A. Orii, A. Horiuchi, T. Toki, and S. Fujii, “Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma,” Gynecologic Oncology, vol. 75, no. 3, pp. 453–459, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Mihara, K. L. Gupta, Z. A. Kartchmer, M. S. Kogutt, and A. E. Robinson, “Leiomyosarcoma after retinoblastoma radiotherapy,” Radiation Medicine, vol. 9, no. 5, pp. 183–184, 1991. View at Google Scholar · View at Scopus